Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Akoya Biosciences Inc
(NQ:
AKYA
)
3.980
+0.020 (+0.51%)
Streaming Delayed Price
Updated: 11:06 AM EDT, May 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Akoya Biosciences Inc
< Previous
1
2
Next >
Akoya Biosciences and Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical Workflows
Today 8:00 EDT
KR-HT5 is based on Akoya’s PhenoImager® HT Platform
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya to Report First Quarter 2024 Financial Results on May 13th, 2024
April 22, 2024
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and Scale
April 05, 2024
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya Reports Record Revenue in the Fourth Quarter of 2023 and Provides Full Year 2024 Financial Outlook
March 04, 2024
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya to Report Fourth Quarter and Full Year 2023 Financial Results on March 4th, 2024 and Participate at an Upcoming Investor Conference
February 08, 2024
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya Biosciences’ Technology Enables Queensland Spatial Biology Centre to Revolutionize the Diagnosis and Treatment of Cancer and Other Diseases
January 18, 2024
PhenoCycler®-Fusion system selected as the Centre’s platform technology for advanced spatial biology studies
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya Biosciences Announces that Garry Nolan, Ph.D., James Allison, Ph.D., and Padmanee Sharma, M.D., Ph.D., Join Newly Created Scientific Advisory Board
January 10, 2024
Leading immunotherapy and immunobiology experts will offer strategic direction and expertise in translational, clinical, and diagnostic applications of Akoya’s spatial biology solutions
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya Biosciences and Thermo Fisher Scientific Announce a License and Distribution Agreement to Deliver Spatial Multiomics Workflow
January 07, 2024
The Thermo Fisher Scientific ViewRNA technology combined with Akoya’s market leading spatial biology solutions will enable rapid, whole-slide imaging of RNA and protein biomarkers
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya Biosciences Deploys the MaxFuse Algorithm Co-Developed by Dr. Garry Nolan and His Laboratory at Stanford University for Multiomic Integration of Spatial and Single-cell Data on the Enable Medicine Platform
January 07, 2024
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya Biosciences Announces Preliminary Financial Results for the Fourth Quarter and Full Year 2023 and Provides 2024 Outlook
January 07, 2024
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya to Participate at 42nd Annual J.P. Morgan Healthcare Conference
December 20, 2023
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya Reports Record Revenue in the Third Quarter of 2023 and Reiterates Full Year 2023 Revenue Guidance
November 08, 2023
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya to Participate at Three Upcoming Investor Conferences
November 02, 2023
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya Biosciences to Showcase New Spatial Biology 2.0 Solutions and Spatial Phenotyping Data at SITC 2023
October 31, 2023
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya Biosciences Announces Peer-Reviewed Publication Using Ultrahigh-Plex Spatial Phenotyping of Head and Neck Cancer to Identify Distinct Immune and Metabolic Signatures
October 17, 2023
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya to Report Third Quarter 2023 Financial Results on November 8th, 2023
October 11, 2023
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya Biosciences Sets a New Standard for Scaling Spatial Biology with the Launch of 2.0 Platforms
September 19, 2023
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya Reports Record Revenue in the Second Quarter of 2023 and Reiterates Full Year 2023 Revenue Guidance
August 07, 2023
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya Biosciences Announces Milestone of 1,000 Peer-Reviewed Publications Citing Use of its Spatial Biology Technologies
August 07, 2023
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya to Participate at Three Upcoming Investor Conferences
July 26, 2023
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya to Report Second Quarter 2023 Financial Results on August 7th, 2023
July 12, 2023
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya to Participate at Two Upcoming Investor Conferences
June 12, 2023
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya Biosciences Announces Pricing of Public Offering of Common Stock
June 08, 2023
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya Biosciences Announces Public Offering of Common Stock
June 07, 2023
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya Reports Record Revenue in the First Quarter of 2023 and Reiterates Full Year 2023 Revenue Guidance
May 08, 2023
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya Biosciences Marks Milestone Achievement with Shipment of 1,000th Spatial Biology Instrument
April 27, 2023
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya Biosciences Introduces PhenoCode Discovery Panels to Simplify PhenoCycler-Fusion Workflow
April 12, 2023
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya Biosciences and Enable Medicine Introduce Cloud Platform to Power Faster Analysis of PhenoCycler-Fusion Data
April 12, 2023
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya to Report First Quarter 2023 Financial Results on May 8th, 2023
April 06, 2023
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya Biosciences Announces Leadership Transition
March 20, 2023
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.